Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-23

Clinical Trial Update: Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia [NA]

View source ↗

Summary

Clinical trial update on Accelerated Neuromodulation Therapy for negative symptoms in schizophrenia; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Douglas Mental Health University Institute | Conditions: Schizophrenia and Predominant Negative Symptoms | NA | Status: RECRUITING